Regulus Therapeutics (NASDAQ:RGLS) Upgraded at StockNews.com
StockNews.com upgraded shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) to a sell rating in a research note released on Tuesday. Several other research firms have also recently weighed in on RGLS. HC Wainwright reaffirmed a buy rating and set a $10.00 price objective on shares of Regulus Therapeutics in a research report on Friday, […]
StockNews.com Initiates Coverage on Sify Technologies (NASDAQ:SIFY)
Equities researchers at StockNews.com started coverage on shares of Sify Technologies (NASDAQ:SIFY – Get Free Report) in a research note issued on Wednesday. The firm set a “sell” rating on the technology company’s stock. Sify Technologies Trading Down 10.5 % Shares of SIFY stock opened at $0.36 on Wednesday. The firm has a 50 day […]
StockNews.com Initiates Coverage on Marine Petroleum Trust (NASDAQ:MARPS)
Stock analysts at StockNews.com began coverage on shares of Marine Petroleum Trust (NASDAQ:MARPS – Get Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the energy company’s stock. Marine Petroleum Trust Price Performance MARPS stock opened at $4.01 on Wednesday. Marine Petroleum Trust has a 1 year low […]
Sotherly Hotels (NASDAQ:SOHO) Coverage Initiated at StockNews.com
StockNews.com initiated coverage on shares of Sotherly Hotels (NASDAQ:SOHO – Free Report) in a research note issued to investors on Tuesday. The firm issued a hold rating on the real estate investment trust’s stock. Separately, Piper Sandler lowered their price objective on shares of Sotherly Hotels from $2.00 to $1.50 and set a neutral rating […]
StockNews.com Initiates Coverage on Nabriva Therapeutics (NASDAQ:NBRV)
StockNews.com assumed coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research note released on Monday. The firm issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance The firm has a market capitalization of $45.46 million, a P/E ratio of -0.07 and a beta of 1.53. Nabriva Therapeutics […]
last updated on 20 Sep 10:50